Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2001
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072767A1 Dehydroepiandrosterone derivatives, preparation method and uses thereof, in particular for cosmetics
10/04/2001WO2001072762A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
10/04/2001WO2001072758A1 Tricyclic protein kinase inhibitors
10/04/2001WO2001072749A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001WO2001072745A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders
10/04/2001WO2001072744A1 N-heterocyclic derivatives as nos inhibitors
10/04/2001WO2001072737A1 Triarylimidazole derivatives as cytokine inhibitors
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072718A1 Pharmaceutical compositions containing as the active ingredient nitropyrimidine derivatives or salts thereof
10/04/2001WO2001072717A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001WO2001072713A1 Non-steroidal, tetracyclic compounds for estrogen-related treatments
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072707A2 Carbamate caspase inhibitors and uses thereof
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072692A1 Malonamic acids and derivatives thereof as thyroid receptor ligands
10/04/2001WO2001072680A1 Substituted chalcones as therapeutic compounds
10/04/2001WO2001072328A2 Methods of treating diseases with activated protein c
10/04/2001WO2001072323A2 Use of insulin for the treatment of cartilagenous disorders
10/04/2001WO2001072308A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001WO2001072296A1 Method of inhibiting the expression of inflammatory cytokines and chemokines
10/04/2001WO2001072290A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
10/04/2001WO2001072281A2 Microspheres for active embolization
10/04/2001WO2001034565A3 Protease inhibitors
10/04/2001WO2001023563A3 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
10/04/2001WO2001019828A3 Kinase inhibitors as therapeutic agents
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
10/04/2001US20010027216 Method for preventing hormone induced adverse effects
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1137774A2 Grnf4, a gdnf-related neurotrophic factor
10/04/2001EP1137773A2 Growth factor homolog zvegf3
10/04/2001EP1137667A2 Analogues of glp-1
10/04/2001EP1137666A1 Glp-1 analogues
10/04/2001EP1137661A1 Procollagen c-proteinase inhibitors
10/04/2001EP1137656A1 31 human secreted proteins
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP1137419A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
10/04/2001EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives
10/04/2001EP1079852B1 Composition based on pentoxifylline and anticytokin
10/04/2001EP0891326B1 Novel vitamin d analogues
10/04/2001EP0880528B1 Spiro-ketal derivatives and their use as therapeutic agents
10/04/2001EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
10/04/2001DE10003767A1 Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika Skin-friendly drug patch for transdermal administration of non-steroidal anti-inflammatory drugs
10/04/2001CA2404901A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001CA2404669A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404660A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2404532A1 Method of identifying inhibitors of tie-2
10/04/2001CA2404445A1 Tricyclic protein kinase inhibitors
10/04/2001CA2404231A1 Methods of treating diseases with activated protein c
10/04/2001CA2403906A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
10/04/2001CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/04/2001CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001CA2402735A1 Human transcription factors
10/04/2001CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
10/04/2001CA2399875A1 Crystal structure of the (aml1 runt domain) / (cbfbeta) heterodimer and the ternary complex with dna
10/04/2001CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001CA2374911A1 G-protein coupled receptors
10/03/2001CN1315856A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
10/03/2001CN1315200A Exterior-applied medicine for treating lumbar intervertebral disk protrusion
10/02/2001US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene
10/02/2001US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions.
10/02/2001US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists
10/02/2001US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure
10/02/2001US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/02/2001US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases
10/02/2001US6297217 Boronic ester and acid compounds, synthesis and uses
10/02/2001US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33
10/02/2001US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1
10/02/2001US6296851 For screening antibiotics
09/2001
09/27/2001WO2001071358A1 Method of screening for inhibitors of osteopontin
09/27/2001WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
09/27/2001WO2001071004A2 Proteases
09/27/2001WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof
09/27/2001WO2001070807A2 G-protein associated molecules
09/27/2001WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
09/27/2001WO2001070766A2 Therapeutic anti-cytomegalovirus compounds
09/27/2001WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1
09/27/2001WO2001070746A1 Furoisoquinoline derivatives, process for producing the same and use thereof
09/27/2001WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors
09/27/2001WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001WO2001070729A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
09/27/2001WO2001070723A1 Benzothiophene derivatives and medicinal use thereof
09/27/2001WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001WO2001070716A1 A process for the preparation of epothilone analogs and intermediates
09/27/2001WO2001070696A1 Nitroethenamine derivatives or salts thereof and pharmaceutical compositions containing the derivatives or the salts
09/27/2001WO2001070695A1 Pyridine derivatives as inhibitors of p38
09/27/2001WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
09/27/2001WO2001070691A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors
09/27/2001WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors
09/27/2001WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
1 ... 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 ... 820